4 Results for "

E-7090

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "E-7090" in MCE Product Catalog:

Cat. No.: HY-101466
CAS No.: 1622204-21-0
Purity:  99.64%
Target:  

FGFR

Research Areas:  

Cancer

E7090 is an orally available, potent, and selective FGFR inhibitor with IC50s of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/FGFR2/FGFR3/FGFR4, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W016412
CAS No.: 605-94-7
Synonyms: CoQ0
Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling .
loading...
    loading...
Cat. No.: HY-101466A
CAS No.: 1879965-80-6
Purity:  99.17%
Target:  

FGFR

Research Areas:  

Cancer

E7090 succinate is an orally available, selective and potent inhibitor of FGFR1, FGFR2 and FGFR3 tyrosine kinase activities, with IC50 values of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/2/3/4, respectively .
loading...
    loading...
Cat. No.: HY-101466R
CAS No.: 1622204-21-0
Research Areas:  

Cancer

E7090 (Standard) is the analytical standard of E7090 (HY-101466). This product is intended for research and analytical applications. E7090 is an orally available, potent, and selective FGFR inhibitor with IC50s of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/FGFR2/FGFR3/FGFR4, respectively .
loading...
    loading...